Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
15 companies reporting in the next 90 days. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Oct 8 · in 42 days · 1 company | |||||
| NRIX | Nurix Therapeutics, Inc. | Oncology | $2.73B | +15.02% | |
| Tuesday, Oct 27 · in 61 days · 1 company | |||||
| RCUS | Arcus Biosciences, Inc. | Oncology | $4.02B | +13.40% | |
| Thursday, Oct 29 · in 63 days · 2 companies | |||||
| 6MK.DE | Merck & Co., Inc. | Oncology | $380.73B | +11.62% | |
| MRK | Merck & Co., Inc. | Oncology | $371.70B | +19.65% | |
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| Monday, Nov 2 · in 67 days · 1 company | |||||
| NUVB | Nuvation Bio Inc. | Oncology | $2.49B | +6.61% | |
| Tuesday, Nov 3 · in 68 days · 1 company | |||||
| COGT | Cogent Biosciences, Inc. | Oncology | $6.39B | −9.00% | |
| Wednesday, Nov 4 · in 69 days · 2 companies | |||||
| TNGX | Tango Therapeutics, Inc. | Oncology | $4.13B | −8.27% | |
| XNCR | Xencor, Inc. Common Stock | Oncology | $2.18B | +47.53% | |
| Thursday, Nov 5 · in 70 days · 4 companies | |||||
| LNTH | Lantheus Holdings, Inc. | Oncology | $6.58B | −6.63% | |
| RLAY | Relay Therapeutics, Inc. | Oncology | $4.51B | +10.35% | |
| IMNM | Immunome, Inc. | Oncology | $3.34B | +30.14% | |
| URGN | UroGen Pharma Ltd. | Oncology | $2.27B | +11.82% | |
| Wednesday, Nov 11 · in 76 days · 3 companies | |||||
| ERAS | Erasca, Inc. | Oncology | $6.16B | −5.88% | |
| CELC | Celcuity Inc. | Oncology | $4.44B | +12.16% | |
| SLS | SELLAS Life Sciences Group, Inc. | Oncology | $2.89B | +29.98% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.